Marshall Financial Group LLC Has $1.22 Million Holdings in RELX PLC $RELX

Key Points

• Marshall Financial Group LLC increased its stake in Relx Plc by 207.4% during Q2, owning 22,859 shares valued at approximately $1.22 million.
• Relx recently cut its dividend to $0.2634 per share, resulting in a dividend yield of 170.0% and a payout ratio of 28.49%.
• While Morgan Stanley maintained an "overweight" rating on Relx, Wall Street Zen downgraded the stock from a "buy" to a "hold" rating, indicating mixed sentiment among analysts.

Marshall Financial Group LLC grew its stake in shares of RELX PLC (NYSE:RELX - Free Report) by 207.4% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 22,859 shares of the technology company's stock after purchasing an additional 15,422 shares during the period. Marshall Financial Group LLC's holdings in RELX were worth $1,222,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of the stock. Wealth Enhancement Advisory Services LLC lifted its holdings in shares of RELX by 2.3% during the second quarter. Wealth Enhancement Advisory Services LLC now owns 42,652 shares of the technology company's stock valued at $2,269,000 after purchasing an additional 943 shares during the last quarter. Sivia Capital Partners LLC lifted its holdings in shares of RELX by 57.9% during the second quarter. Sivia Capital Partners LLC now owns 7,005 shares of the technology company's stock valued at $381,000 after purchasing an additional 2,568 shares during the last quarter. Aaron Wealth Advisors LLC lifted its holdings in shares of RELX by 7.0% during the second quarter. Aaron Wealth Advisors LLC now owns 18,717 shares of the technology company's stock valued at $1,017,000 after purchasing an additional 1,218 shares during the last quarter. Gradient Investments LLC lifted its holdings in shares of RELX by 21.3% during the second quarter. Gradient Investments LLC now owns 12,930 shares of the technology company's stock valued at $703,000 after purchasing an additional 2,271 shares during the last quarter. Finally, Parallel Advisors LLC raised its position in RELX by 4.1% during the second quarter. Parallel Advisors LLC now owns 8,422 shares of the technology company's stock valued at $458,000 after buying an additional 329 shares during the period. 15.02% of the stock is owned by hedge funds and other institutional investors.

RELX Stock Down 1.1%

NYSE:RELX traded down $0.52 during trading hours on Friday, hitting $47.09. 1,170,348 shares of the company's stock traded hands, compared to its average volume of 1,506,443. The company has a debt-to-equity ratio of 2.55, a quick ratio of 0.42 and a current ratio of 0.47. RELX PLC has a twelve month low of $44.19 and a twelve month high of $56.33. The stock's fifty day moving average price is $49.14 and its two-hundred day moving average price is $51.05. The firm has a market cap of $86.30 billion, a P/E ratio of 25.32, a P/E/G ratio of 3.10 and a beta of 0.87.

RELX Cuts Dividend

The company also recently announced a semi-annual dividend, which was paid on Tuesday, September 16th. Shareholders of record on Friday, August 8th were given a $0.2634 dividend. This represents a yield of 170.0%. The ex-dividend date of this dividend was Friday, August 8th. RELX's dividend payout ratio is presently 28.49%.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on RELX. Morgan Stanley reissued an "overweight" rating on shares of RELX in a research report on Thursday, September 11th. Wall Street Zen lowered RELX from a "buy" rating to a "hold" rating in a research report on Friday, September 5th. Four investment analysts have rated the stock with a Buy rating, According to MarketBeat.com, RELX presently has a consensus rating of "Buy".

RELX Company Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.